SAM CHUN DANG PHARM CO. LTD Logo

SAM CHUN DANG PHARM CO. LTD

000250 | KO

Overview

Corporate Details

ISIN(s):
KR7000250001
LEI:
Country:
South Korea
Address:
경기도 화성시 향남읍 제약공단2길 71, 화성시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

No description available.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-19 00:00
Share Issue/Capital Change
[기재정정]주요사항보고서(교환사채권발행결정)
Korean 30.5 KB
2025-09-19 00:00
Transaction in Own Shares
[기재정정]주요사항보고서(자기주식처분결정)
Korean 40.4 KB
2025-09-19 00:00
Transaction in Own Shares
자기주식처분결과보고서
Korean 22.0 KB
2025-09-19 00:00
Share Issue/Capital Change
증권발행결과(자율공시)
Korean 7.4 KB
2025-08-27 00:00
Capital/Financing Update
주요사항보고서(교환사채권발행결정)
Korean 25.0 KB
2025-08-27 00:00
Transaction in Own Shares
주요사항보고서(자기주식처분결정)
Korean 32.5 KB
2025-08-14 00:00
Interim / Quarterly Report
반기보고서 (2025.06)
Korean 2.2 MB
2025-07-30 00:00
AGM Information
임시주주총회결과
Korean 9.2 KB
2025-07-24 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 100.9 KB
2025-07-24 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 25.2 KB
2025-07-24 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.1 KB
2025-07-07 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 61.1 KB
2025-06-30 00:00
Regulatory Filings
[기재정정]단일판매ㆍ공급계약체결(자율공시)
Korean 19.9 KB
2025-06-24 00:00
Director's Dealing
임원ㆍ주요주주특정증권등거래계획보고서
Korean 41.3 KB
2025-06-24 00:00
Director's Dealing
임원ㆍ주요주주특정증권등거래계획보고서
Korean 41.2 KB

Automate Your Workflow. Get a real-time feed of all SAM CHUN DANG PHARM CO. LTD filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for SAM CHUN DANG PHARM CO. LTD

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for SAM CHUN DANG PHARM CO. LTD via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

INOVIO PHARMACEUTICALS, INC. Logo
Develops DNA medicines delivered via smart devices for cancer, HPV, and infectious diseases.
United States of America
INO
INSMED Inc Logo
Develops and commercializes innovative therapies for serious and rare diseases.
United States of America
INSM
Instil Bio, Inc. Logo
Developing autologous TIL cell therapies using a patient's own immune cells to fight solid tumors.
United States of America
TIL
INTENSITY THERAPEUTICS, INC. Logo
Develops injected therapies to kill tumors locally and activate a systemic immune response.
United States of America
INTS
Intercure Ltd. Logo
Develops and distributes pharmaceutical-grade medical cannabis for patients and pharmacies globally.
Israel
INCR
Intervacc AB Logo
Develops recombinant protein vaccines and diagnostics for animal health, like Strangvac® for horses.
Sweden
IVACC
iNtRON Biotechnology, Inc. Logo
Develops phage therapeutics and molecular diagnostics to combat infectious diseases.
South Korea
048530
Inventiva Logo
Clinical-stage biopharma developing oral therapies for fibrosis, oncology, & lysosomal disorders.
France
IVA
Inventiva S.A. Logo
Develops oral small molecule therapies for NASH, fibrosis, and rare metabolic disorders.
United States of America
IVA
Invivyd, Inc. Logo
Develops evolution-resistant antibodies to protect against viral diseases like COVID-19 and flu.
United States of America
IVVD

Talk to a Data Expert

Have a question? We'll get back to you promptly.